









Markets
/
Stocks
/
nasdaq-tcrx
/

TScan Therapeutics Inc

TCRX

1.710USD

+0.090+5.56%

Close 08/04, 16:00（ET）Quotes delayed by 15 min

96.77MMarket Cap

LossP/E TTM



TScan Therapeutics Inc

1.710

+0.090+5.56%

Overview Company Financials

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

Total revenue

283.57%2.17M

-90.78%665.00K

-73.01%1.05M

-82.97%536.00K

-91.68%566.00K

132.99%7.21M

15.58%3.89M

-22.39%3.15M

125.19%6.80M

8.44%3.10M

39.43%3.36M

42.42%4.06M

49.04%3.02M

258.99%2.85M

731.72%2.41M

--2.85M

--2.03M

--795.00K

--290.00K

--0.00

Revenue

283.57%2.17M

-90.78%665.00K

-73.01%1.05M

-82.97%536.00K

-91.68%566.00K

132.99%7.21M

15.58%3.89M

-22.39%3.15M

125.19%6.80M

8.44%3.10M

39.43%3.36M

42.42%4.06M

49.04%3.02M

258.99%2.85M

731.72%2.41M

--2.85M

--2.03M

--795.00K

--290.00K

--0.00

Operating expenses

20.29%38.42M

30.84%37.38M

17.59%33.67M

24.83%34.65M

8.10%31.94M

31.38%28.57M

43.60%28.64M

43.81%27.76M

54.01%29.55M

27.49%21.74M

9.24%19.94M

42.69%19.30M

92.90%19.18M

98.21%17.06M

144.66%18.25M

140.87%13.53M

76.45%9.95M

--8.61M

--7.46M

--5.62M

--5.64M

R&D expenses

17.82%29.29M

31.01%29.35M

15.48%26.26M

26.62%26.88M

14.13%24.86M

43.59%22.41M

51.29%22.74M

46.45%21.23M

48.26%21.78M

23.76%15.60M

5.81%15.03M

34.19%14.49M

100.16%14.69M

111.40%12.61M

144.38%14.21M

139.92%10.80M

70.75%7.34M

--5.96M

--5.81M

--4.50M

--4.30M

Depreciation, depletion, and amortization

-45.93%678.00K

-44.45%711.00K

-20.14%1.03M

-13.89%1.12M

-16.34%1.25M

-13.75%1.28M

2.80%1.29M

7.37%1.30M

25.44%1.50M

29.95%1.48M

18.47%1.25M

82.60%1.21M

154.80%1.20M

188.38%1.14M

205.20%1.06M

148.50%661.00K

111.26%469.00K

--396.00K

--346.00K

--266.00K

--222.00K

Operating profit

-15.55%-36.25M

-71.90%-36.71M

-31.82%-32.62M

-38.62%-34.11M

-37.95%-31.37M

-14.52%-21.36M

-49.28%-24.75M

-61.42%-24.61M

-40.71%-22.74M

-31.31%-18.65M

-4.65%-16.58M

-42.77%-15.25M

-104.13%-16.16M

-81.84%-14.20M

-120.92%-15.84M

-90.15%-10.68M

-40.49%-7.92M

---7.81M

---7.17M

---5.62M

---5.64M

Net non-operating interest income (expenses)

Non-operating interest income

27.95%2.80M

6.97%2.78M

35.13%3.69M

121.97%3.41M

92.78%2.19M

188.12%2.60M

411.80%2.73M

929.53%1.53M

16128.57%1.14M

44950.00%901.00K

17700.00%534.00K

2880.00%149.00K

16.67%7.00K

-33.33%2.00K

200.00%3.00K

66.67%5.00K

-93.94%6.00K

--3.00K

--1.00K

--3.00K

--99.00K

Non-operating interest expense

-29.20%679.00K

-7.98%784.00K

-2.44%958.00K

-1.75%952.00K

0.31%959.00K

-12.62%852.00K

388.56%982.00K

--969.00K

--956.00K

--975.00K

--201.00K

----

Special income (expenses)

----

---1.09M

----

Income before tax

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

Income after tax

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

Net income from continuous operations

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

Net income attributable to controlling interests

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

Net income attributable to common shareholders

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

Basic earnings per share

17.16%-0.26

-43.92%-0.30

-3.83%-0.25

45.19%-0.28

65.89%-0.32

73.52%-0.21

64.06%-0.24

18.82%-0.51

-38.21%-0.93

-29.17%-0.78

-0.49%-0.67

-38.64%-0.63

-100.90%-0.67

-81.89%-0.60

-120.91%-0.67

-90.17%-0.45

-42.89%-0.34

---0.33

---0.30

---0.24

---0.23

Diluted earnings per share

17.16%-0.26

-43.92%-0.30

-3.83%-0.25

45.19%-0.28

65.89%-0.32

73.52%-0.21

64.06%-0.24

18.82%-0.51

-38.21%-0.93

-29.17%-0.78

-0.49%-0.67

-38.64%-0.63

-100.90%-0.67

-81.89%-0.60

-120.91%-0.67

-90.17%-0.45

-42.89%-0.34

---0.33

---0.30

---0.24

---0.23

Dividend per share

--0.00

Currency unit

USD

Audit opinions

KeyAI

